Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Atherosclerosis|May 27, 2009
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteriesStephane S Silvera, Hamza El Aidi, James H F Rudd, et al.
The New England Journal of Medicine|November 7, 2025
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving HemodialysisCharmaine E Lok, Michael Farkouh, Brenda R Hemmelgarn, et al.
The Canadian Journal of Cardiology|April 9, 2024
Socioeconomic Disparities in Women's Cardiovascular Health in the United States and CanadaGurleen Kaur, Diane Masket, Tina Reddy, et al.
American Heart Journal|November 26, 2019
Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle interventionJacqueline Latina, Rodrigo Fernandez-Jimenez, Sameer Bansilal, et al.
BMJ Open|January 29, 2025
Efficacy of the Foodbot Factory digital curriculum-based nutrition education intervention in improving children's nutrition knowledge, attitudes and behaviours in elementary school classrooms: protocol for a cluster randomised controlled trialJacqueline Marie Brown, Saman Tahir, Beatriz Franco-Arellano, et al.
The American Journal of the Medical Sciences|June 4, 2014
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart diseaseChristopher M Gamboa, Monika M Safford, Emily B Levitan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2008
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendationsJames H F Rudd, Kelly S Myers, Sameer Bansilal, et al.
American Heart Journal|October 8, 2013
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trialSorin J Brener, Jose M Dizon, Roxana Mehran, et al.
Atherosclerosis|March 11, 2015
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndromeJuan Gaztanaga, Michael Farkouh, James H F Rudd, et al.
Journal of the American Heart Association|February 8, 2022
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI TrialDavide Capodanno, Dominick J Angiolillo, Ryan J Lennon, et al.
Pageof 4